• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾母细胞瘤原代细胞对自然杀伤细胞和巨噬细胞具有强大的免疫调节特性。

Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages.

作者信息

Fiore Piera Filomena, Vacca Paola, Tumino Nicola, Besi Francesca, Pelosi Andrea, Munari Enrico, Marconi Marcella, Caruana Ignazio, Pistoia Vito, Moretta Lorenzo, Azzarone Bruno

机构信息

Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, 25121 Brescia, Italy.

出版信息

Cancers (Basel). 2021 Jan 9;13(2):224. doi: 10.3390/cancers13020224.

DOI:10.3390/cancers13020224
PMID:33435455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826641/
Abstract

The immune response plays a crucial defensive role in cancer growth and metastasis and is a promising target in different tumors. The role of the immune system in Wilm's Tumor (WT), a common pediatric renal malignancy, is still to be explored. The characterization of the immune environment in WT could allow the identification of new therapeutic strategies for targeting possible inhibitory mechanisms and/or lowering toxicity of the current treatments. In this study, we stabilized four WT primary cultures expressing either a blastematous (CD56/CD133) or an epithelial (CD56/CD133) phenotype and investigated their interactions with innate immune cells, namely NK cells and monocytes. We show that cytokine-activated NK cells efficiently kill WT cells. However, after co-culture with WT primary cells, NK cells displayed an impaired cytotoxic activity, decreased production of IFNγ and expression of CD107a, DNAM-1 and NKp30. Analysis of the effects of the interaction between WT cells and monocytes revealed their polarization towards alternatively activated macrophages (M2) that, in turn, further impaired NK cell functions. In conclusion, we show that both WT blastematous and epithelial components may contribute directly and indirectly to a tumor immunosuppressive microenvironment that is likely to play a role in tumor progression.

摘要

免疫反应在癌症生长和转移中起着至关重要的防御作用,是不同肿瘤中有前景的治疗靶点。免疫系统在常见的儿童肾恶性肿瘤——肾母细胞瘤(WT)中的作用仍有待探索。对WT免疫环境的特征分析有助于确定新的治疗策略,以针对可能的抑制机制和/或降低现有治疗的毒性。在本研究中,我们稳定了四种表达胚基(CD56/CD133)或上皮(CD56/CD133)表型的WT原代培养物,并研究了它们与天然免疫细胞(即NK细胞和单核细胞)的相互作用。我们发现细胞因子激活的NK细胞能有效杀伤WT细胞。然而,与WT原代细胞共培养后,NK细胞的细胞毒性活性受损,IFNγ产生减少,CD107a、DNAM-1和NKp30的表达降低。对WT细胞与单核细胞相互作用的影响分析表明,它们向交替激活的巨噬细胞(M2)极化,进而进一步损害NK细胞功能。总之,我们表明WT的胚基和上皮成分可能直接和间接促成肿瘤免疫抑制微环境,这可能在肿瘤进展中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/65bd819d13f9/cancers-13-00224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/2610fd37806f/cancers-13-00224-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/5c5a5d4e21cb/cancers-13-00224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/6305796ed616/cancers-13-00224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/79dd37f99331/cancers-13-00224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/c79c73b60be1/cancers-13-00224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/65bd819d13f9/cancers-13-00224-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/2610fd37806f/cancers-13-00224-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/5c5a5d4e21cb/cancers-13-00224-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/6305796ed616/cancers-13-00224-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/79dd37f99331/cancers-13-00224-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/c79c73b60be1/cancers-13-00224-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb4/7826641/65bd819d13f9/cancers-13-00224-g006.jpg

相似文献

1
Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages.肾母细胞瘤原代细胞对自然杀伤细胞和巨噬细胞具有强大的免疫调节特性。
Cancers (Basel). 2021 Jan 9;13(2):224. doi: 10.3390/cancers13020224.
2
Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' Tumors.小儿肿瘤对自然杀伤细胞的抑制作用:以神经母细胞瘤和肾母细胞瘤为例
Cancers (Basel). 2021 May 14;13(10):2374. doi: 10.3390/cancers13102374.
3
Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells.基质样肾母细胞瘤细胞诱导人类自然杀伤细胞脱颗粒,并对自然杀伤细胞表现出免疫调节特性。
Oncoimmunology. 2021 Mar 8;10(1):1879530. doi: 10.1080/2162402X.2021.1879530.
4
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.突变型 von Hippel-Lindau-肾细胞癌 (RCC) 可促进患者特异性自然杀伤 (NK) 细胞的细胞毒性。
J Exp Clin Cancer Res. 2018 Dec 4;37(1):297. doi: 10.1186/s13046-018-0952-7.
5
Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer.共存的甲状腺自身免疫性疾病的性质决定了甲状腺癌肿瘤免疫的成败。
J Immunother Cancer. 2019 Jan 7;7(1):3. doi: 10.1186/s40425-018-0483-y.
6
MicroRNA-215-5p Inhibits the Proliferation and Migration of Wilm's Tumor Cells by Targeting CRK.miR-215-5p 通过靶向 CRK 抑制肾母细胞瘤细胞的增殖和迁移。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211036523. doi: 10.1177/15330338211036523.
7
Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.间变性肾母细胞瘤及其相关上皮细胞系的独特性质。
Am J Pathol. 1994 May;144(5):1023-34.
8
Etiology of Wilms' tumor.肾母细胞瘤的病因
Epidemiol Rev. 1995;17(2):415-32. doi: 10.1093/oxfordjournals.epirev.a036201.
9
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors.前列腺癌外周血 NK 细胞表现出增强的 CD9、CD49a、CXCR4、CXCL8、MMP-9 的产生,并分泌单核细胞募集和极化因子。
Front Immunol. 2021 Jan 25;11:586126. doi: 10.3389/fimmu.2020.586126. eCollection 2020.
10
Human peripheral blood DNAM-1 NK cells are a terminally differentiated subset with limited effector functions.人类外周血 DNAM-1 NK 细胞是终末分化的亚群,具有有限的效应功能。
Blood Adv. 2019 Jun 11;3(11):1681-1694. doi: 10.1182/bloodadvances.2018030676.

引用本文的文献

1
The pan-immune-inflammation value predicts prognosis and chemotherapy-related adverse events in Wilms' tumor patients.全免疫炎症值可预测肾母细胞瘤患者的预后及化疗相关不良事件。
BMC Cancer. 2025 Jun 1;25(1):979. doi: 10.1186/s12885-025-14391-7.
2
Gene Expression Analysis of (Paired) Primary and Relapsed Wilms Tumor Samples to Unravel the Underlying Factors Driving Tumor Recurrence.(配对的)原发性和复发性肾母细胞瘤样本的基因表达分析,以揭示驱动肿瘤复发的潜在因素。
Cancer Med. 2025 Jun;14(11):e70969. doi: 10.1002/cam4.70969.
3
Predicting the prognosis of Wilms tumor by peripheral blood cells: a real-world study of more than 30 years.

本文引用的文献

1
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation.在与激活协同作用下,针对癌症靶点时,人自然杀伤细胞上的TIM-3表达下调。
Cancers (Basel). 2020 Aug 26;12(9):2417. doi: 10.3390/cancers12092417.
2
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.免疫抑制性 IDO 在癌症中的作用:作用机制、动物模型和靶向策略。
Front Immunol. 2020 Jun 16;11:1185. doi: 10.3389/fimmu.2020.01185. eCollection 2020.
3
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
通过外周血细胞预测 Wilms 瘤的预后:一项超过 30 年的真实世界研究。
Ital J Pediatr. 2024 Nov 14;50(1):245. doi: 10.1186/s13052-024-01805-8.
4
Recruitment and polarization typing of tumor-associated macrophages is associated with tumor progression and poor prognosis in Wilms tumor patients.肿瘤相关巨噬细胞的募集和极化分型与 Wilms 瘤患者的肿瘤进展和预后不良有关。
PLoS One. 2024 Nov 12;19(11):e0309910. doi: 10.1371/journal.pone.0309910. eCollection 2024.
5
Construction of a Wilms tumor risk model based on machine learning and identification of cuproptosis-related clusters.基于机器学习构建肾母细胞瘤风险模型及鉴定铜死亡相关簇
BMC Med Inform Decis Mak. 2024 Nov 4;24(1):325. doi: 10.1186/s12911-024-02716-8.
6
Identification of m6A-associated genes as prognostic and immune-associated biomarkers in Wilms tumor.鉴定m6A相关基因作为肾母细胞瘤的预后和免疫相关生物标志物
Discov Oncol. 2023 Nov 8;14(1):201. doi: 10.1007/s12672-023-00817-w.
7
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance.肿瘤微环境诱导的肿瘤细胞可塑性:与缺氧应激的关系及其对肿瘤耐药性的影响。
Front Oncol. 2023 Oct 11;13:1222575. doi: 10.3389/fonc.2023.1222575. eCollection 2023.
8
Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches.小儿实体瘤的靶向免疫激活:补充局部控制方法的机会。
Front Immunol. 2023 Jun 22;14:1202169. doi: 10.3389/fimmu.2023.1202169. eCollection 2023.
9
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers.NK 细胞和 NK 细胞来源的可溶性因子对源自原发性或转移性胰腺癌的细胞系的不同影响。
Cancer Immunol Immunother. 2023 Jun;72(6):1417-1428. doi: 10.1007/s00262-022-03340-z. Epub 2022 Nov 30.
10
Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour.巨噬细胞和单核细胞介导的氧化磷酸化激活与肾母细胞瘤的预后及临床治疗策略相关。
Comput Struct Biotechnol J. 2022 Jun 27;20:3399-3408. doi: 10.1016/j.csbj.2022.06.052. eCollection 2022.
IL15 刺激联合 TIGIT 阻断逆转黑色素瘤中 CD155 介导的 NK 细胞功能障碍。
Clin Cancer Res. 2020 Oct 15;26(20):5520-5533. doi: 10.1158/1078-0432.CCR-20-0575. Epub 2020 Jun 26.
4
The future of cancer immunotherapy: microenvironment-targeting combinations.癌症免疫疗法的未来:靶向微环境的联合疗法。
Cell Res. 2020 Jun;30(6):507-519. doi: 10.1038/s41422-020-0337-2. Epub 2020 May 28.
5
A guide to cancer immunotherapy: from T cell basic science to clinical practice.癌症免疫疗法指南:从 T 细胞基础科学到临床实践。
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
6
Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?靶向治疗:是患者自然杀伤细胞介导的肿瘤免疫监视的帮手还是敌人?
Cancers (Basel). 2020 Mar 25;12(4):774. doi: 10.3390/cancers12040774.
7
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.单细胞和患者队列的表达谱分析鉴定出胶质母细胞瘤中的多种免疫抑制途径和改变的 NK 细胞表型。
Clin Exp Immunol. 2020 Apr;200(1):33-44. doi: 10.1111/cei.13403. Epub 2019 Dec 16.
8
NK Cell-Based Immunotherapy for Hematological Malignancies.基于自然杀伤细胞的血液系统恶性肿瘤免疫疗法
J Clin Med. 2019 Oct 16;8(10):1702. doi: 10.3390/jcm8101702.
9
Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis.低级别或高级腹膜癌患者肿瘤相关 NK 细胞的不同特征。
Front Immunol. 2019 Aug 21;10:1963. doi: 10.3389/fimmu.2019.01963. eCollection 2019.
10
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function.肝肿瘤微环境及其对 NK 细胞表型和功能的影响。
Int J Mol Sci. 2019 Aug 24;20(17):4131. doi: 10.3390/ijms20174131.